Medical conditions
[용어속성] Term
Molecular Architecture of Early Dissemination and Massive Second Wave of the SARS-CoV-2 Virus in a Major Metropolitan Area
Research Article
[키워드] acute respiratory syndrome
Amino acid
amino acid replacement
amino acid replacements
Analysis
architecture
Area
caused
Community
coronavirus
coronavirus disease
COVID-19
COVID-19 disease
CR3022
defined
Diagnosis
disease
disease severity
Evidence
Evolution
Features
future infection
generate
Genome
Genome sequencing
genomic
genomic data
Genotype
help
host genetics
Host immune response
Houston
Infection
infections
initial
introduced
Major
massive
Medical conditions
molecular
molecular population genomics
monoclonal antibody
nasopharynx
Neutralizing
pandemic
Patient
polymorphism
produced
provide
Receptor binding domain
Region
SARS-CoV-2
SARS-CoV-2 evolution
SARS-CoV-2 strain
second
second wave
sequenced
significantly higher
Spike protein
strain
subsequent
the SARS-CoV-2
the spike protein
therapeutic
trajectory
Transmission
Vaccine
variant
virulence
virus
virus genotype
virus load
Wave
[DOI] 10.1128/mBio.02707-20 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1128/mBio.02707-20 PMC 바로가기 [Article Type] Research Article
Antihypertensive drugs are associated with reduced fatal outcomes and improved clinical characteristics in elderly COVID-19 patients
Article
[키워드] ACEi
acute respiratory syndrome
addition
Antihypertensive drug
ARB
association
Autoimmunity
baseline
blocker
Blood
clinical
Clinical characteristics
Clinical outcome
clinical outcomes
conducted
CoV
COVID-19
COVID-19 patient
COVID-19 patients
CRP
D dimer
disease severity
diuretics
drug
drugs
Dyspnea
Elderly patient
fatigue
Gender
hemoglobin
Hospitalization
hypertension
laboratory-confirmed
Logistic regression
Lymphocyte count
Medical conditions
multicenter
multivariate
Novel coronavirus
Older
outbreak
outcome
Patient
patients
procalcitonin
reduced
reduction
Retrospective study
RNAi
significantly
spread to
statistical adjustment
statistically
Wuhan, China
[DOI] 10.1038/s41421-020-00221-6 PMC 바로가기 [Article Type] Article
[DOI] 10.1038/s41421-020-00221-6 PMC 바로가기 [Article Type] Article
Laboratory markers associated with COVID‐19 progression in patients with or without comorbidity: A retrospective study
동반이환 또는 동반이환이 없는 환자의 COVID-19 진행과 관련된 검사실 표지자: 후향적 연구
Multicenter Study
[키워드] age
Analysis
assessments
Biomarker
C‐reactive protein
collinearity
Comorbidities
Coronavirus disease‐19 (COVID‐19)
COVID‐19
COVID‐19 infection
COVID‐19 patient
COVID‐19 patients
Cox proportional hazard
CRP
D‐dimer
death
diabetes
discriminant analysis
disease severity
followed by
hypertension
independent risk factor
indicated
Laboratory
laboratory biomarkers
Lactate
lactate dehydrogenase
LDH
liver
liver diseases
Logistic regression analysis
lymphopenia
marker
Medical conditions
Mortality
mortality risk
mortality risk factors
multicenter
multivariable
multivariable logistic regression
Multivariable logistic regression analysis
objective
partial least square
pathophysiological mechanism
Patient
patients with comorbidities
PCA
performed
prealbumin
Principal component
principal component analysis
progression
regression analysis
Result
Retrospective study
risk
risk factor
Risk factors
severity
survival analysis
was performed
was related
[DOI] 10.1002/jcla.23644 PMC 바로가기 [Article Type] Multicenter Study
[DOI] 10.1002/jcla.23644 PMC 바로가기 [Article Type] Multicenter Study
A Case Control Study to Evaluate the Impact of Colchicine on Patients Admitted to the Hospital with Moderate to Severe COVID-19 Infection
Research Article
Published on
Journal: The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien des Maladies Infectieuses et de la Microbiologie Médicale [Category] COVID-19,
Journal: The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien des Maladies Infectieuses et de la Microbiologie Médicale [Category] COVID-19,
[키워드] addition
Analysis
Arthritis
benefit
carried
center
Colchicine
colchicine group
comprehensive analysis
condition
Control
control group
control patient
coronavirus disease
COVID-19
CRP
discharge rate
Efficacy
febrile illness
ferritin
Final
form
Future
group
Hyperinflammatory
Impact
Inflammatory marker
inflammatory markers
initial
intubation
lactate dehydrogenase
lower mortality
Medical conditions
moderate
New York City
outcome
patients
patients with COVID-19
performed
placebo-controlled clinical trial
Prevalence
prevalent
Protein
Randomized
receiving
renal
Result
selected
serum
significant decrease
Standard of care
statistically significant
the patient
therapy
were given
[DOI] 10.1155/2020/8865954 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1155/2020/8865954 PMC 바로가기 [Article Type] Research Article
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
생명을 위협하는 COVID-19 환자에서 I형 IFN 면역의 선천적 오류
Research Article
[키워드] a minor
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
administration
Affect
affecting
age
amplification
amplification pathway
Asymptomatic
autoantibodies
autoantibody
autoantibody system
autosomal-dominant
autosomal-recessive
Beck
biochemically
BOLD
candidate gene approach
caused
cellular
clinical
Clinical course
Clinical outcome
clinical variability
complete penetrance
complex
component
components
core gene
core genes
coronavirus
coronavirus disease
Coronavirus disease 2019
Course
COVID
COVID Human Genetic Effort
COVID-19
COVID-19 patient
COVID-19 pneumonia
Critical
Critical disease
cytokine
Cytokines
damage
dampen
deficiencies
deficiency
defined
Deleterious
dendritic cell
dendritic cells
determine
Diseases
double-stranded RNA
eight
enrichment
epidemiological studies
Exome
fibroblast
fibroblasts
Genes
genes encoding
genetic defect
genetic defects
genetics
Genome
genomics study
had milder phenotype
healthy individuals
highest
Hospitalized
Human
human fibroblasts with mutations
Hypothesis
identify
IFN
IFN response
IFN-α2
IFNAR1
IFNAR1 deficiency
IFNAR2
IFNs
IKBKG
immune system
Immunity
immunological
in healthy individuals
in some
in vitro
Inborn error
Inborn errors
incomplete penetrance
individual
induction pathway
Infection
infection with SARS-CoV-2
Infectious diseases
Influenza
influenza pneumonia
Influenza virus
inheritance
interferon
interferon regulatory factor
interferon regulatory factor 7
interferons
interferons (IFNs)
involved
IRF3
IRF7
IRF9
lack
life-threatening
likelihood
loci
LOF
loss-of-function
male
mechanism
Medical conditions
minor
minor allele frequency
molecular
molecule
molecules
monogenic inborn error
monogenic inborn errors
mutated
Mutation
NEMO
NEMO/IKBKG
Neutralizing
nonsynonymous variant
other variants
outcome
pathogen
pathogen-induced inflammation
pathway
Patient
patients
Perspective
plasmacytoid dendritic cells
pLOF
Pneumonia
predicted
Prevent
produced
rare variant
Rare variants
Regulation
respiratory
reveal
risk
risk factor
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 infection in vitro
Science
selected
sequenced
severe acute respiratory syndrome Coronavirus
severe acute respiratory syndrome coronavirus 2
severe coronavirus disease
severe COVID-19
Severe COVID-19 pneumonia
severe disease
Severe infection
silent infection
Stat1
STAT2
subject
susceptible
TBK1
tested
Therapeutic benefit
this system
TICAM1
TICAM1/TRIF
tissue
TLR3
Toll-like receptor
Toll-like receptor 3
TRAF3
TRIF
Type
type I
Type I IFN
type I IFNs
type I interferon
UNC93B1
underlie
variant
variants
Viral
Viral illness
viral illnesses
[DOI] 10.1126/science.abd4570 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1126/science.abd4570 PMC 바로가기 [Article Type] Research Article
Managing the combined consequences of COVID-19 infection and lock-down policies on athletes: narrative review and guidelines proposal for a safe return to sport
Review
[키워드] affected
appear
approach
biological profile
cardiac complication
Cardiology
Cardiovascular disorders
clinical manifestation
Community
consequence
cough
COVID-19
COVID-19 infection
COVID-19 pandemic
diabete
disease spread
Dyspnoea
evaluate
exercise
fatigue
Fever
globe
headache
Health
hypertension
hypoxaemia
individual
individuals
managing
Medical conditions
MONITOR
multiorgan failure
myalgia
myocarditis
occur
physical ability
Physiology
Postinfection
reduce
reported
respiratory
Respiratory failure
risk
Safe
severe cases
Shock
sore throat
sports & exercise medicine
stoppage
Symptom
Symptoms
symptoms of COVID-19
the disease
[DOI] 10.1136/bmjsem-2020-000849 PMC 바로가기 [Article Type] Review
[DOI] 10.1136/bmjsem-2020-000849 PMC 바로가기 [Article Type] Review
Tissue Proteases and Immune Responses: Influencing Factors of COVID-19 Severity and Mortality
Review
[키워드] acute respiratory syndrome
Affect
affected
age
agency
Asthma
caused
Characteristics
confirmed cases
contribute
coronavirus
coronavirus disease
COVID-19
Critically ill
current
develop
diabetes
disease outcome
disease severity
expression level
Factor
genetic variants
Host
host factors
hypertension
immune response
immune responses
incidence
individual
intrinsic
Medical conditions
Mortality
outcome
populations
profile
protease
Proteins
question
reported
SARS-CoV-2
severe disease
Stage
suggested
Surveillance
susceptibility
the disease
those with comorbidity
tissue
tissue proteases
[DOI] 10.3390/pathogens9100817 PMC 바로가기 [Article Type] Review
[DOI] 10.3390/pathogens9100817 PMC 바로가기 [Article Type] Review
ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives
Molecular Biosciences
[키워드] “cytokine storm”
accumulates
ACE
ACE inhibitor
ACE2
ACE2 expression
ACE2 protein
ACE2 receptor
acute respiratory syndrome
Administered
Alter
Angiotensin receptor blockers
angiotensin-converting enzyme 2
antibodies
appear
binding
biochemical
Biochemistry
cardioprotection
cardiovascular system
cellular
clinical investigation
competitive binding
COVID-19
COVID-19 disease
COVID-19 pandemic
Cytokine storm
determinant
downregulation
drugs
Effect
effort
engage
enzyme
Epigenetic
event
Evidence
exogenously
forms
glycosylation
Host
host cell membrane
hypertension
induce
Infection
initial
Interaction
intestine
kidney
knowledge
limit
Lung inflammation
mammalian
mechanism
Medical conditions
MicroRNAs
modulation
Neutralizing
novel
observation
pathogenicity
pathophysiological
pathophysiology
peptides
Phosphorylation
plasma membrane
Protein
reduce
reduced
regulated
Replication
respiratory tract
responsible
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV2
severe COVID-19
small molecule
Spike protein
Strategy
subunits: S1
tissues
transcriptional
viral envelope
viral genome
virus
virus entry
[DOI] 10.3389/fmolb.2020.588618 PMC 바로가기 [Article Type] Molecular Biosciences
[DOI] 10.3389/fmolb.2020.588618 PMC 바로가기 [Article Type] Molecular Biosciences
Clinical presentation of paediatric patients with COVID-19 admitted to a single paediatric intensive care unit (PICU) in Iran
Intensive Care
[키워드] cardiac arrhythmias
children
clinical
Clinical characteristics
cough
COVID-19
cross-sectional
died
Fever
Health services research
intensive care
Iran
Medical conditions
Mortality
objective
paediatric patient
paediatric patients
Respiratory failure
Result
Ventilation
Virology
with COVID-19
[DOI] 10.1136/bmjpo-2020-000715 PMC 바로가기 [Article Type] Intensive Care
[DOI] 10.1136/bmjpo-2020-000715 PMC 바로가기 [Article Type] Intensive Care